Checking the Overall Picture for Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $61.28, down from yesterday’s close by -0.79%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Bristol-Myers Squibb Company (BMY) currently trades with a market capitalization of $101.10 Billion. That value represents a market adjusting for revenues that have been growing by 6.75 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $4.42 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.67 on a per share basis this quarter. Perhaps, that suggests something about why 0.36% of the outstanding share supply is held by institutional investors.

Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Bristol-Myers Squibb Company recorded a 52-week high of $66.10. It is now trading 4.82% off that level. The stock is trading $62.03 its 50-day moving average by 0.75%. The stock carved out a 52-week low down at $46.01.

In recent action, Bristol-Myers Squibb Company (BMY) has made a move of -3.02% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.70% with $1.63 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BMY.

Previous articlePhillips 66 (PSX): What’s the Story?
Next articleHow Does Lam Research Corporation (LRCX) Stack Up Right Now?